Article citationsMore>>
Chianella, C., Gragnaniello, D., Delser, P.M., Visentini, M.F., Sette, E., Tola, M.R., Barbujani, G. and Fuselliet, S. (2011) BCHE and CYP2D6 Genetic Variation in Alzheimer’s Disease Patients Treated with Cholinesterase Inhibitors. European Journal of Clinical Pharmacology, 67, 1147-1157.
http://dx.doi.org/10.1007/s00228-011-1064-x
has been cited by the following article:
-
TITLE:
Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia
AUTHORS:
Beate Mueller, Georg Adler
KEYWORDS:
Butyrylcholinesterase, Alzheimer’s Disease, Genotype
JOURNAL NAME:
World Journal of Neuroscience,
Vol.5 No.3,
June
2,
2015
ABSTRACT: Approximately, two-thirds patients
with Alzheimer’s disease (AD) are reported to have homozygous wild-type
butyrylcholinesterase (BuChE) gene expression. It is associated with a higher
rate of hydrolysis of acetylcholine, which ultimately leads to increase in the
levels of BuChE in advanced stages of the disease. Rivastigmine, a dual
inhibitor of acetylcholinesterase (AChE) and BuChE, might be of additional
benefit in patients with AD with wild-type BuChE allele.
Related Articles:
-
Tsuyoshi Komori, Isamu Narabayashi, Yoshifumi Narumi, Taisuke Inomata
-
Elisabetta Giugni, Rita Vadalà, Francesca Romana Pezzella, Giuseppe Bomboi, Stefano Galletti, Giacomo Luccichenti, Carmela Colica, Orietta Picconi, Stefano Bastianello
-
Jennifer R. Bowes, Patrick Stroman, Angeles Garcia
-
Jolanta Dorszewska, Agata Różycka, Anna Oczkowska, Jolanta Florczak-Wyspiańska, Michał Prendecki, Mateusz Dezor, Izabela Postrach, Paweł P. Jagodzinski, Wojciech Kozubski
-
Anna Vespa, Maria Velia Giulietti, Marica Ottaviani, R. Spatuzzi, F. Merico, Guido Gori, Olimpia Claudia Rossi, L. Paciaroni, Giuseppe Pelliccioni, Pietro Scendoni, Cristina Meloni